Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
NU E Power Corp. Announces Completion of Unwinding its Acquisition of Blu Dot Systems Inc. (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Johnson and Johnson JNJ

Healthcare Drug Manufacturers - Major
Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious... see more

Current News (NYSE:JNJ)

Johnson & Johnson Announces FDA Approval of TECNIS PureSee Intraocular Lens, a Breakthrough Solution for U.S. Cataract Patients

Business Wire 11 hours ago

Johnson & Johnson to Host Investor Conference Call on First-Quarter Results

Business Wire 10 days ago

Johnson & Johnson Expands U.S. Footprint with more than $1 Billion Investment in Next Generation Cell Therapy Manufacturing Facility in Pennsylvania

Business Wire February 18, 2026

Philadelphia Jury Returns $250,000 Verdict Against J&J in Latest Baby Powder-Ovarian Cancer Trial

Business Wire February 13, 2026

Johnson & Johnson to Participate in the Barclays 28th Annual Global Healthcare Conference

Business Wire February 9, 2026

Johnson & Johnson Presents Early Outcomes from the OMNY-AF Pilot Study at 2026 AF Symposium

Business Wire February 6, 2026

Johnson & Johnson to Participate in the TD Cowen 46th Annual Health Care Conference

Business Wire February 2, 2026

Johnson & Johnson Marks $100 Million of MedTech Products Donated Since 2020 to Help People Live, See and Smile

Business Wire January 27, 2026

Johnson & Johnson reports Q4 and Full-Year 2025 results

Business Wire January 21, 2026
View More News ››

Opinion & Analysis (NYSE:JNJ)

The ProMIS of an Alzheimer's cure

The Life Sciences Report May 4, 2017

Investment in cell and gene therapies ramps up

The Life Sciences Report June 8, 2016

What Andy Grove and Michael Milken have taught us about prostate cancer

The Life Sciences Report April 20, 2016

Use stock volatility to invest in innovative oncology companies: JMP Security's Michael King Jr.

Gail Dutton October 15, 2015

Bearish On Bucks? Try This ETF

Benzinga.com  September 18, 2015

Eight iconic American companies that have been hurt by the strong dollar

Stockhouse Editorial September 10, 2015
View More Opinion ››

Bullboard Posts (NYSE:JNJ)

Rate cuts are pulling attention toward growth sectors

Hi J&J followers!   Rate cuts are pulling attention toward growth sectors, but what does this mean for healthcare giants...
cmarketinsights - December 10, 2024

JNJ: Strong Pharma Growth, But Legal Risks Remain ⚠️

JNJ’s pharma division is crushing it, with big hits like Imbruvica and Darzalex driving revenue. But the ongoing legal battles—especially...
SmartBull65 - December 3, 2024

$JNJ Steady but Slow: Where’s the Spark?

Johnson & Johnson ($JNJ) is a safe, steady name but lacks growth oomph. Diagnostic biotech firms, like MYNZ, bring the innovation...
WealthLine48 - November 26, 2024

JNJ's Flatline: Buy Opportunity?

I’ve been watching JNJ, and despite its steady dividends, the stock is stuck around $155. Promising drug trials like their psoriasis...
SmartBull65 - November 24, 2024

Is $JNJ Ready to Bounce Back?

Just checked the chart on $JNJ—looks like it’s been consolidating for a minute. Could see a reversal soon if support holds at $152. Also...
TradeDriver718 - November 22, 2024

Will this ever turn around?

EOM.
BSdetector2016 - April 5, 2024
View more Bullboard ››

Laser Photonics Corp.

Laser Photonics Corp.

Laser Photonics Corporation operates as a vertically integrated manufacturing company for photonics-based industrial products ...
View More »

Podcasts